These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1733189)

  • 21. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
    Sivin I
    Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
    Kamau RK; Maina FW; Kigondu C; Mati JK
    East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbohydrate metabolism in sickle cell patients using a subdermal implant containing nomegestrol acetate (Uniplant).
    Barbosa IC; Ladipo OA; Nascimento ML; Athayde C; Hirsch C; Lopes R; Matias B; Coutinho E
    Contraception; 2001 May; 63(5):263-5. PubMed ID: 11448467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cytology associated with levonorgestrel contraception.
    Misra JS; Engineer AD; Tandon P
    Acta Cytol; 1995; 39(1):45-9. PubMed ID: 7847008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of blood glucose and plasma insulin in "normal" women using mechanical contraception for 6 months.
    Spellacy WN; Buhi WC; Birk SA
    Am J Obstet Gynecol; 1975 Dec; 123(8):786-9. PubMed ID: 1106200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of the estrogen-progesterone combination preparations gravistat and Minisiston on carbohydrate metabolism].
    Albus C; Männchen E
    Zentralbl Gynakol; 1987; 109(8):521-6. PubMed ID: 3111130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma immunoglobulin, total protein and albumin levels during Norplant use by Nigerian women.
    Otolorin EQ; Adeyefa I; Konje JC; Ojengbede O; Osotimehin B; Ladipo OA
    Acta Obstet Gynecol Scand; 1993 Nov; 72(8):645-7. PubMed ID: 8259752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Let's talk about Norplant: advances in steroidal contraception].
    Martinez JE
    Profamilia; 1992 Dec; 8(20):28-34. PubMed ID: 12286384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Norplant contraceptive implants in the immediate postpartum period: safety and tolerance.
    Phemister DA; Laurent S; Harrison FN
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):175-9. PubMed ID: 7847530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral contraceptives and insulin receptor binding in normal women and those with previous gestational diabetes.
    Skouby SO; Andersen O; Kühl C
    Am J Obstet Gynecol; 1986 Oct; 155(4):802-7. PubMed ID: 3766633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial angiogenic response in Norplant users.
    Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
    Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innovations in contraception: the Norplant system.
    Klaisle CM; Wysocki S
    NAACOGS Clin Issu Perinat Womens Health Nurs; 1992; 3(2):267-79. PubMed ID: 1596435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests -- a randomized comparative study with Norplant implants.
    Biswas A; Biswas S; Viegas OA
    Contraception; 2004 Nov; 70(5):379-82. PubMed ID: 15504376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical study of endometrial microvascular basement membrane components in women using Norplant.
    Palmer JA; Lau TM; Hickey M; Simbah M; Rogers PA
    Hum Reprod; 1996 Oct; 11(10):2142-50. PubMed ID: 8943519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of enlarged ovarian follicles among users of levonorgestrel subdermal contraceptive implants (Norplant).
    Alvarez-Sanchez F; Brache V; de Oca VM; Cochon L; Faúndes A
    Am J Obstet Gynecol; 2000 Mar; 182(3):535-9. PubMed ID: 10739504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IMAP statement on Norplant subdermal contraceptive implant system.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1993 Apr; 27(2):1-3. PubMed ID: 12345306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P; Lähteenmäki P; Rutanen EM
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.